Hepatocellular Carcinoma (HCC) Summit

Welcome to the third Hepatocellular Carcinoma (HCC) Summit: From basic to clinical research: How to improve HCC clinical care? to be held in Geneva, Switzerland from 1-3 March 2018.

Brought to you by the European Association for the Study of the Liver (EASL). 

HCC is considered one of the most important causes of death in patients affected with chronic liver disease. In the past years, major advances in the early diagnosis and treatment, particularly in advanced stages, have taken place.

This Summit will cover both the basic and translational/clinical aspects of the disease, with a specific focus on new targeted therapies in HCC. Great efforts have been made in the scientific programme to enhance the interaction among basic scientists, clinical researchers, and industry leaders to stimulate our combined efforts in addressing the key challenges in HCC.

To view an online programme, or to learn moire about this event or EASL, please click here.